Jiangsu Delfu Medical Devices Co., LTD., officially established in May 2010, is one of the wholly-owned subsidiaries of Jiangsu Huayang Intelligent Equipment Co., LTD., with more than 15 years of industry experience in the field of precision drug delivery. The company is mainly engaged in the design, production, sales and service of mechanical pen injector, electronic pen injector, Internet of Things intelligent electronic pen injector, micro injection pump related products.
At the beginning of the company to provide customers with every product into the "Delfu" team "Dedicated, Professional, Confident, Insistent, Concerted, Cohesive" dedication quality and professional standards. And fully understand the wishes and needs of customers, adhering to the parent company's core concept of "quality achievement development, innovation to create the future", after nearly 13 years of precipitation:
In terms of technological innovation, we have been recognized as a high-tech enterprise, a municipal high-tech product and two municipal engineering technology research centers. We have also obtained more than 50 independent patents, including more than 7 invention patents, 1 German patent and 5 computer software Copyrights.
In terms of quality control management, our ISO13485 system has obtained TUV certification approval, a number of pen syringes have obtained the registration certificate of medical devices, and some products have obtained the EU CE certification, which guarantees the value of "Delfu" products;
In terms of products, we have formed 5 product platforms, 14 types of basic products, and have formed cooperation with more than 20 pharmaceutical factories at home and abroad. Successfully used in 9 diseases (diabetes, osteoporosis, short stature, infertility, Parkinson, etc.) 14 drugs (insulin, GLP1, growth hormone, teriparatide, follicle stimulating hormone, etc.) microprecise drug delivery subcutaneous injection treatment.
Different groups, different drugs have different needs for micro-precision drug delivery devices, "Delfu" series of products is the spirit of "to provide patients with high quality, affordable injection devices; To provide precise drug delivery solutions for pharmaceutical enterprises; The product concept of "Providing health management equipment for high-end demand groups" is designed in combination with the administration characteristics of different drugs and the characteristics of different drug groups. We do not let go of every detail in the production process, strict control, with the best and most rigorous design scheme and manufacturing means, so that every drop of liquid medicine can play its due value......
more >
Year of Establishment:
2010
Total Assets(USD):
500,000 to 99,999,999
Total Number of Staff:
100-500
Main Competitive Advantages:
Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service
Other Competitive Advantages:
In terms of products, we have formed 5 product platforms, 14 types of basic products, and have formed cooperation with more than 20 pharmaceutical factories at home and abroad. Successfully used in 9 diseases (diabetes, osteoporosis, short stature, infertility, Parkinson, etc.) 14 drugs (insulin, GLP1, growth hormone, teriparatide, follicle stimulating hormone, etc.) microprecise drug delivery subcutaneous injection treatment.
Different groups, different drugs have different needs for micro-precision drug delivery devices, "Delfu" series of products is the spirit of "to provide patients with high quality, affordable injection devices; To provide precise drug delivery solutions for pharmaceutical enterprises; The product concept of "Providing health management equipment for high-end demand groups" is designed in combination with the administration characteristics of different drugs and the characteristics of different drug groups. We do not let go of every detail in the production process, strict control, with the best and most rigorous design scheme and manufacturing means, so that every drop of liquid medicine can play its due value......
Patents and Copyrights:
In terms of technological innovation, Delfu have been recognized as a high-tech enterprise, a municipal high-tech product and two municipal engineering technology research centers. We have also obtained more than 50 independent patents, including more than 7 invention patents, 1 German patent and 5 computer software Copyrights.
Business Type:
All,Agent,Distributor,Trading Company,Retailer,Service Provider,Manufacturer
R&D capacity:
OEM,ODM,Own Brand
Annual Turnover(USD):
500,000 to 99,999,999
Main Sales Markets:
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Other Competitive Advantages:
In terms of products, we have formed 5 product platforms, 14 types of basic products, and have formed cooperation with more than 20 pharmaceutical factories at home and abroad. Successfully used in 9 diseases (diabetes, osteoporosis, short stature, infertility, Parkinson, etc.) 14 drugs (insulin, GLP1, growth hormone, teriparatide, follicle stimulating hormone, etc.) microprecise drug delivery subcutaneous injection treatment.
Different groups, different drugs have different needs for micro-precision drug delivery devices, "Delfu" series of products is the spirit of "to provide patients with high quality, affordable injection devices; To provide precise drug delivery solutions for pharmaceutical enterprises; The product concept of "Providing health management equipment for high-end demand groups" is designed in combination with the administration characteristics of different drugs and the characteristics of different drug groups. We do not let go of every detail in the production process, strict control, with the best and most rigorous design scheme and manufacturing means, so that every drop of liquid medicine can play its due value......
Patents and Copyrights:
In terms of technological innovation, Delfu have been recognized as a high-tech enterprise, a municipal high-tech product and two municipal engineering technology research centers. We have also obtained more than 50 independent patents, including more than 7 invention patents, 1 German patent and 5 computer software Copyrights.